Fundamental dimension Equity attribute | AFALXPeer $14.37▼-0.96% Cap $31.77MP/E -15.8x QuantScore48/100 | ADVGXPeer $9.02▼-39.83% Cap $11.23MP/E — QuantScore31/100 | CVLEXLeader $18.08▼-0.88% Cap $31.13MP/E — QuantScore78/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
31/100 |
78/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | — | — |
Health Piotroski, Altman Z, leverage & liquidity | 25/100 | — | — |
Growth Revenue / earnings growth & margins | 41/100 | — | — |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -15.8x | — | — |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | -4.6x | — | — |
Price / Sales | 0.6x | — | — |
Price / Free Cash Flow | 0.6x | — | — |
PEG ratio | -0.69 | — | — |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | — | — |
Altman Z-Score | -0.67 (Distress) | — | — |
Total debt / equity | 0.72 | — | — |
Quick ratio | 0.0x | — | — |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +2.7% | — | — |
Net income growth YoY | +18.2% | — | — |
Gross margin (TTM) | 100.0% | — | — |
Operating margin (FY) | 82.9% | — | — |
FCF margin (FY) | 99.3% | — | — |
5. Trailing price performancePrice change over period |
1M return | +5.0% | -40.7% | +0.1% |
3M return | +4.7% | -44.3% | -2.3% |
6M return | +14.2% | -34.8% | +7.4% |
Year to date | +19.0% | -31.8% | +15.7% |
1Y return | +20.4% | -35.6% | +15.7% |
3Y return | +51.1% | -1.7% | +43.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-26.17 -282.1% premium | — — | — — |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |